Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project

Haematologica. 2020 Jan;105(1):e33-e36. doi: 10.3324/haematol.2019.223016. Epub 2019 Aug 1.

Clément Bailly^{1

2}, Thomas Carlier^{1

2}, Alina Berriolo-Riedinger³, Olivier Casasnovas⁴, Emmanuel Gyan⁵, Michel Meignan⁶, Anne Moreau⁷, Barbara Burroni⁸, Loïc Djaileb⁹, Remy Gressin¹⁰, Anne Devillers¹¹, Thierry Lamy^{12

13}, Catherine Thieblemont¹⁴, Olivier Hermine¹⁵, Françoise Kraeber-Bodéré^{1

2

16}, Steven Le Gouill^{17

18}, Caroline Bodet-Milin^{1

2}

¹ CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes.
² Department of Nuclear Medicine, CHU Nantes, Nantes.
³ Department of Nuclear Medicine, CLCC Georges François Leclerc.
⁴ Department of Hematology, CHU Dijon Bourgogne, Dijon.
⁵ Department of Hematology, CHU Tours, Tours.
⁶ LYSA Imaging, Creteil.
⁷ Department of Pathology, CHU Nantes, Nantes.
⁸ Department of Pathology, CHU Paris Hôpital Cochin, Paris.
⁹ Department of Nuclear Medicine, CHU Grenoble-Alpes, Grenoble.
¹⁰ Onco Hematology Department, Hospital University Grenoble, La Tronche, Grenoble.
¹¹ Department of Nuclear Medicine, CLCC Eugene Marquis.
¹² Department of Hematology, CHU Rennes.
¹³ Inserm U1236, University of Rennes, Rennes.
¹⁴ Onco Hematology Department, CHU Paris-GH St-Louis Lariboisière.
¹⁵ Department of Hematology, CHU Paris - Hôpital Necker-Enfants Malades, Paris.
¹⁶ Department of Nuclear Medicine, ICO-René Gauducheau, Saint-Herblain.
¹⁷ CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes steven.legouill@chu-nantes.fr.
¹⁸ Department of Hematology, CHU Nantes, Nantes, France.

No abstract available

Publication types